Skip to main content
Equibles
CALC logo

CALC · CalciMedica, Inc.

Track CALC — free

Use CALC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CALC

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.59 0.00 (-0.09%) At close · Aug 26
Going-concern doubt — flagged Aug 11, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on our current operating plans, we believe our cash and cash equivalents will be sufficient to fund our current operations into the second half of 2027. As a result, there is substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 11, 2026
Market Cap
$20.08M
Shares
34.14M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.59 Open$0.60 Day$0.57–0.60 52W close$0.51–6.74 Avg vol 30d309K Short int323K · 0.9% float · 1.0d Short vol56% Last earningsNov 7, 2025 DataJun 2023–Aug 2026 Filing10-Q · Aug 11

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 11, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Very Bullish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 15.2 · calm Equity put/call 0.64
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −68%
below
Price vs 50-day avg −23%
below
RSI (14) 40
neutral
MACD trend Negative
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −21%
trailing
6-month return −11%
trailing
YTD return −91%
this year
Relative strength −24%
vs S&P · 6-mo
Sentiment
smart money
Very Bullish
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+14% holders QoQ · +10 funds added
Insider flow Accumulating
Net +$200.0K over 90 days · 0% sells
Short interest Falling
0.95% of float · ▼ -35.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
32 holders — near 3-yr high, broad support
Squeeze score 42
elevated · 0–100
Fundamentals
Weak
EPS growth −61%
Y/Y
Free cash flow $-21.2M
Balance sheet $11.5M
net cash
Quant / Vol
risk profile
Very High
Volatility 143%
annualized · 1-yr
Max drawdown −92%
past year
ATR 11.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−68% Bearish
Price vs 50-day avg
−23% Bearish
RSI (14)
40 Neutral
MACD trend
Negative Bearish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+14% holders QoQ · +10 funds added
Insider flow Accumulating
Net +$200.0K over 90 days · 0% sells
Short interest Falling
0.95% of float · ▼ -35.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
32 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $1 · 1% Range high $7
vs 200-day avg -68% vs 50-day avg -23%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CALC
CalciMedica, Inc.
this stock
$20.08M -91.1% — — 0.9%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $138.72B +20.7% +46.2% 31.9 1.6%
REGN
Regeneron Pharmaceuticals, Inc.
 $83.89B +5.6% +20.8% 20.2 2.3%
ARGX
Argenx SE
 $63.81B +24.5% — — 1.9%
CSLLY
Csl Ltd
 $60.07B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
32
% held
24.6%
Net QoQ
+7.3M sh
Top holder
Woodline Partners LP
Held Float
View
Held by Funds
Fund positions
6
View
Short & Settlement
Short Interest Falling
Shares short
323.2K
Days to cover
1.0d
Change
-179.8K sh
View
Short Volume
Short vol %
56%
As of
Aug 26, 2026
Short Total
View
Fails to Deliver
FTD shares
1.1K
Value
$886
As of
Jul 31, 2026
View
Off-Exchange
Off-exchange %
46.1%
Week of
Jul 20, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$200.0K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Net income (FY)
$-29.6M
EPS diluted
$-1.97
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 20, 2026
This year
15
View
Exempt Offerings
Offering
$9.1M
Filed
Apr 4, 2023
View
Earnings & Events
Earnings Calls
Last call
Nov 7, 2025
View
Investor Relations
Latest news
CalciMedica Reports Second Quarte…
Published
Aug 11, 2026
View

Performance

5D 20D 120D MTD YTD
CALC -4.2% -20.9% -11.1% -41.3% -91.1%
SPY -0.4% +5.0% +12.4% +2.6% +12.3%
vs SPY -3.8% -26.0% -23.6% -43.8% -103.4%
Key facts CIK 1534133 CUSIP 38942Q202 13F (30d) 35 filings 33 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)